Teresa Brophy Bair Kura Oncology, Inc. (KURA) insider trading activity

Teresa Brophy Bair is Chief Legal Officer of Kura Oncology, Inc.. Currently has a direct ownership of 226,931 shares of KURA, which is worth approximately $2.54 Million. The most recent transaction as insider was on Jan 27, 2026, when has been sold 11,208 shares (Common Stock) at a price of $8.46 per share, resulting in proceeds of $94,819. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 227K

53.29% 3M change

110.22% 12M change

Total Value Held $2.54 Million

Teresa Brophy Bair Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 27 2026	SELL Open market or private sale	$94,819 $8.46 p/Share	11,208 Reduced 4.71%	226,931 Common Stock
Jan 02 2026	BUY Grant, award, or other acquisition	-	50,000 Added 17.35%	238,139 Common Stock
Nov 14 2025	SELL Open market or private sale	$98,428 $11.18 p/Share	8,804 Reduced 4.47%	188,139 Common Stock
Nov 13 2025	BUY Grant, award, or other acquisition	-	48,900 Added 19.89%	196,943 Common Stock
Sep 29 2025	SELL Open market or private sale	$78,716 $8.94 p/Share	8,805 Reduced 5.61%	148,043 Common Stock
Sep 27 2025	BUY Grant, award, or other acquisition	-	48,900 Added 23.77%	156,848 Common Stock
May 19 2025	SELL Open market or private sale	$9,291 $5.96 p/Share	1,559 Reduced 1.42%	107,948 Common Stock

Jan 28 2025	SELL Open market or private sale	$57,301 $7.87 p/Share	7,281 Reduced 6.32%	107,948 Common Stock
Jan 02 2025	BUY Grant, award, or other acquisition	-	46,250 Added 28.64%	115,229 Common Stock
May 20 2024	SELL Open market or private sale	$57,922 $22.15 p/Share	2,615 Reduced 3.65%	68,979 Common Stock
Jan 29 2024	SELL Open market or private sale	$36,543 $17.8 p/Share	2,053 Reduced 2.89%	68,979 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	46,250 Added 39.43%	71,032 Common Stock
Feb 16 2023	BUY Grant, award, or other acquisition	-	23,125 Added 50.0%	23,125 Common Stock
Nov 17 2022	SELL Open market or private sale	$31,962 $15.22 p/Share	2,100 Reduced 100.0%	0 Common Stock

Also insider at

ATNX

Athenex, Inc. Healthcare

General Counsel, SVP Admin.

TBB